Evidence map›Paper›PMID 42305297›Full record

ArticleArchives of medical science : AMS2026

Hydroxysafflor yellow A improves diabetes-induced renal fibrosis.

Qihui Li, Fan Li, Zhongpei Chen, Suntian Deng, Xinli Cao, Nengyuan Tang

Abstract read
In one paragraph

Article in Archives of medical science : AMS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Qihui LiDepartment of Nephrology, Chongqing Traditional Chinese Medicine Hospital, Chongqing, China.
Fan LiDepartment of Nephrology, Chongqing Traditional Chinese Medicine Hospital, Chongqing, China.
Zhongpei ChenDepartment of Endocrinology, Chongqing Traditional Chinese Medicine Hospital, Chongqing, China.
Suntian DengDepartment of Nephrology, Chongqing Traditional Chinese Medicine Hospital, Chongqing, China.
Xinli CaoDepartment of Nephrology, Chongqing Traditional Chinese Medicine Hospital, Chongqing, China.
Nengyuan TangDepartment of Nephrology, Chongqing Traditional Chinese Medicine Hospital, Chongqing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: This study aimed to discuss the use of hydroxysafflor yellow A (HSYA) to improve renal fibrosis induced by diabetes and its relative mechanisms, as well as to evaluate the level of renal histopathology and fibrosis in different rat groups. Material and methods: Sprague-Dawley (SD) rats ( Results: In the Conclusions: HSYA improved diabetes-induced renal fibrosis by regulating miRNA-140-5p.

Indexed as

hydroxysafflor yellow AmiRNA-140-5pNF-κB(p65)renal fibrosisTLR4

Identifiers

PMID42305297
PMCPMC13266752

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.